| Pharmos Corporation Add to My Watchlist | (OTCPK: PARS) |
|
|
|||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||
|
|
|
| Thu, Nov 12, 2009 | ||
|
|
Pharmos Corporation Reports 2009 Third Quarter Results - PR Newswire | |
| Wed, Oct 21, 2009 | ||
|
|
Pharmos Corporation Engages Cowen to Assist the Company with Accelerating a Partnership for Dextofisopam - PR Newswire | |
| Mon, Sep 14, 2009 | ||
|
|
Pharmos Announces Results of Phase 2b Irritable Bowel Syndrome Study - PR Newswire | |
| Wed, Aug 12, 2009 | ||
|
|
Pharmos Corporation Reports 2009 Second Quarter Results - PR Newswire | |
| Tue, May 12, 2009 | ||
|
|
Pharmos Corporation Reports 2009 First Quarter Results - PR Newswire | |
| More Featured Content | ||
|
| Conference Calls for PARS |
| 11/05/07 |
|
Special Conference
Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference Archive for PARS |
| 03/15/06 |
|
Business News
Pharmos Agrees to Acquire Vela Pharmaceuticals Inc. Archive for PARS |
| 02/27/06 |
|
Special Conference
The Wall Street Analyst Forum |
| 04/28/05 |
|
Q1 2005 Earnings
Archive for PARS |
| 03/09/05 |
|
Q4 2004 Earnings
Archive for PARS |
This financial channel has been developed exclusively for PR Newswire.com. For private-label solutions, please direct all inquiries to info@financialcontent.com. |
![]()
|